Aerosol formulation for inhalation containing an anticholinergic agent

Details for Australian Patent Application No. 2003298473 (hide)

Owner Boehringer Ingelheim Pharma GmbH & Co. KG

Inventors Schmidt, Friedrich

Agent Davies Collison Cave

Pub. Number AU-B-2003298473

PCT Number PCT/EP2003/0082

PCT Pub. Number WO2004/022052

Priority 102 37 232.2 14.08.02 DE; 102 40 257.4 31.08.02 DE

Filing date 25 July 2003

Wipo publication date 29 March 2004

Acceptance publication date 23 April 2009

International Classifications

A61K 31/33 (2006.01) - Heterocyclic compounds

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 102 37 232.2 14.08.02 DE; 102 40 257.4 31.08.02 DE

13 May 2004 Application Open to Public Inspection

  Published as AU-B-2003298473

23 April 2009 Application Accepted

  Published as AU-B-2003298473

20 August 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003298474-Herbal formualtion containing centella asiatica and sesamum indicum as brain tonic

2003298472-A process for the preparation of 2-hydroxy carboxylic acids